In order to better characterize the clinical presentation of women with a PV in a moderate penetrance ovarian cancer-risk gene, we evaluated women with a PV in BRIP1, RAD51C, or RAD51D identified during hereditary cancer genetic testing. Here, BRIP1 is linked to ovarian carcinoma.